Company Profiles

driven by the PitchBook Platform

Cleave Biosciences

Cleave Biosciences
2010 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Series B LATEST DEAL TYPE
$37M LATEST DEAL AMOUNT
11 INVESTORS
Description

Developer of oncology pharmaceuticals targeting pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
866 Malcolm
Suite 100
Burlingame, CA 94010
United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cleave Biosciences’s full profile, request a free trial.

Cleave Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 08-Aug-2016 $37M 0000 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 09-Apr-2013 0000 0000 000.00 Completed Startup
1. Early Stage VC (Series A) 14-Nov-2011 $44M $44M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cleave Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Cleave Biosciences Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arcus Ventures Venture Capital Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
Nextech Invest Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
5AM Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Cleave Biosciences Executive Team (17)

Name Title Board
Seat
Contact
Info
Mark Rolfe Ph.D President & Chief Scientific Officer
Daniel Anderson Director, Biology
Michael Longhi Director, Project Management
Raymond Deshaies Ph.D Scientific Co-Founder & Advisory Board
Seth Cohen Ph.D Scientific Co-Founder & Advisory Board

5 Former Executives

You’re viewing 5 of 17 executives. Get the full list »

Cleave Biosciences Board Members (11)

Name Representing Role Since Contact
Info
Alfred Scheidegger Ph.D Nextech Invest Board Member 000 0000
Andrew Schwab 5AM Ventures Board Member 000 0000
Carol Gallagher New Enterprise Associates Board Member 000 0000
Dennis Henner Ph.D Clarus Ventures Board Member 000 0000
Jonathan Root MD US Venture Partners Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com